pre-IPO PHARMA

COMPANY OVERVIEW

Celsius Therapeutics is focused on developing precision therapeutics through a deep understanding of the cellular ecosystem of disease. Their team members share a drive to transform the practice of medicine by developing breakthrough medicines. Their culture is rigorous, fast-paced, collaborative and fun, bringing together passionate individuals who want to make an impact.


LOCATION

  • Cambridge, MA, USA

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Oncology

  • WEBSITE

    https://celsiustx.com


    CAREER WEBSITE

    https://celsiustx.com/careers/


    SOCIAL MEDIA


    INVESTORS

    alexandria-venture-investments casdin-capital gv heitage-provider-network third-rock-ventures


    PRESS RELEASES


    Aug 3, 2023

    Celsius Therapeutics Announces Initiation of Dosing in Phase 1 Clinical Trial of CEL383, an Anti-TREM1 Antibody for the Treatment of Inflammatory Bowel Disease


    Feb 27, 2023

    Celsius Therapeutics to Present Preclinical Data on Anti-TREM1 Antibody at 18th Congress of ECCO - Inflammatory Bowel Diseases


    Jan 19, 2023

    Celsius Therapeutics to Present Preclinical Data on Anti-TREM1 Antibody for Inflammatory Bowel Disease at 2023 Crohn’s and Colitis Congress


    Oct 4, 2022

    Applied BioMath, LLC Announces a Continuation of their Collaboration with Celsius Therapeutics for Systems Pharmacology Modeling in Inflammatory Bowel Disease


    Sep 22, 2022

    Celsius Therapeutics Names Scientific Advisers


    For More Press Releases


    Google Analytics Alternative